Drug Approval | July 11, 2023
NMPA approval for first BCMA CAR-T Therapy paves way for more multiple myeloma cell therapies, says GlobalData
Approval to dramatically change CAR-T therapies landscape
Approval to dramatically change CAR-T therapies landscape
Exothera will manufacture Meissa’s MV-012-968 vaccine candidate under CGMP regulations to supply Phase 2 clinical trials
The booster vaccine can be administered safely to individuals who have received two doses of either Covaxin or Covishield
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
Pfizer is likely to show GSK significant competition
Authorisation will help protect adults 60 years of age and older in 30 European countries* from RSV disease for the first time
Capnopharm’s new CapnoPen is the first PIPAC nebulizer to obtain CE marking under the new MDR regulation 2017/745
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
PM emphasises the need to enhance lab surveillance & testing of all Severe Acute Respiratory Illness (SARI) cases & ramp up genome sequencing
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
Subscribe To Our Newsletter & Stay Updated
